Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

PMCBPMCB
15 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in PHARMACYTE BIOTECH INC

NewEdge Advisors, LLC holds 2 shares of PMCB (PHARMACYTE BIOTECH INC), worth $2 as of 2026-Q2.

Current Value

$2

Current Shares

2

Total Value Change

+$2

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2
0.0%
$20.0%$0.77
0
2026-Q1
Unchanged
2
0.0%
$10.0%$0.71
0
2025-Q4
Unchanged
2
0.0%
$10.0%$0.72
0
2025-Q3
Unchanged
2
0.0%
$20.0%$0.98
0
2025-Q2
Unchanged
2
0.0%
$20.0%$1.03
0
2025-Q1
Unchanged
2
0.0%
$30.0%$1.32
0
2024-Q4
Unchanged
2
0.0%
$30.0%$1.55
0
2024-Q3
Unchanged
2
0.0%
$40.0%$1.84
0
2024-Q2
Decreased
2
-33.3%
$40.0%$1.96
0
2024-Q1
Unchanged
3
0.0%
$70.0%$2.37
0
2023-Q4
Unchanged
3
0.0%
$60.0%$2.16
0
2023-Q3
Increased
3
+50.0%
$60.0%$2.10
11
2023-Q2
Unchanged
2
0.0%
$60.0%$2.86
0
2023-Q1
Unchanged
2
0.0%
$60.0%$2.85
0
2022-Q4
New
2
-
$00.0%$2.93
17

Other major holders of PMCB: GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used